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Introduction
Clinical use of opioids is limited and illicit use exacerbated by adverse effects that include development of tolerance and withdrawal during chronic use (Williams et al., 2001) . Abrupt cessation of chronic opioid use produces an intense withdrawal syndrome manifested by dysphoric and aversive signs in both humans and animal models (Williams et al., 2001) , which contributes to drug seeking and high rates of relapse . It is well established that different components of the global withdrawal response arise from distinct structures in the brain Williams et al., 2001; Hyman et al., 2006) . Among these the ventral tegmental area (VTA) and nucleus accumbens (NAc) are thought to contribute to the aversive signs of opioid withdrawal (Koob et al., 1989; Stinus et al., 1990; Gracy et al., 2001 ). Opioid withdrawal is associated with decreased activity of dopaminergic neurons and decreased dopamine output to the NAc (Pothos et al., 1991; Rossetti et al., 1992; Diana et al., 1995; Mazie-Robison et al., 2011) , and is also associated with strong induction of the activity-related immediate early gene, c-Fos, in neurons of the NAc after precipitation of withdrawal (Hayward et al., 1990; Rasmussen et al., 1995; Georges et al., 2000; Gracy et al., 2001; Hamlin et al., 2001; Bagley et al., 2011) .
Conversely, acutely administered opioids increase activity of dopaminergic neurons in the ventral tegmental area (VTA) (Diana et al., 1995; Johnson and North, 1992) and increase dopamine release in the NAc (Pothos et al., 1991) , an effect that is thought to mediate reward (Hyman et al., 2006) . Acute opioids also increase c-Fos expression in neurons of the NAc (Chang et al., 1988; Liu et al., 1994; Garcia et al., 1995; Bontempi and Sharp, 1997; Taracha et al., 2006) .
The finding that both naloxone-precipitated opioid withdrawal and acute morphine administration increased c-Fos expression in NAc, despite their opposing effects on dopamine release and aversion, suggests that different populations of MSNs may be involved. Most neurons in the striatum and the NAc (∼95%) are GABAergic medium-sized spiny neurons (MSNs) (Kawaguchi, 1997) , and are subdivided into two intermingled populations according to their projection targets and their selective expression of dopamine receptor types (Gerfen et al., 1990) . Striatonigral MSNs express D1-type receptors (D1Rs) and constitute the 'direct-pathway' of the basal ganglia, whereas striatopallidal MSNs express D2-type receptors (D2Rs) and constitute the 'indirect-pathway' (Alexander et al., 1986; Gerfen et al., 1990) .
Previous double in situ hybridization studies of c-fos, D1R and preproenkephalin mRNAs in rats found considerable overlap in induction of c-fos in NAc striatonigral and striatopallidal populations during opioid withdrawal (Georges et al., 2000) . More recently, bacterial artificial chromosome (BAC) transgenic animals with targeted expression of eGFP in D1R (drd1a-eGFP mouse) and D2R (drd2-eGFP) expressing MSNs (Gong et al., 2003) have been used to unequivocally identify D1R (striatonigral) and D2R (striatopallidal) expressing MSNs Bertran-Gonzalez et al., 2010) . This approach has identified strong functional segregation among striatonigral and striatopallidal populations in response to drugs selectively acting on D1Rs and/or D2Rs ). The present study therefore used these two BAC transgenic lines to determine if D1R or D2R expressing populations of NAc MSNs are differentially activated by opioid withdrawal. The effects of naloxone-precipitated opioid-withdrawal, as well as acute morphine, on the co-localization of c-Fos immunoreactivity and eGFP were examined by confocal microscopy in different territories of the NAc. A striking segregation of the neuronal populations engaged in the two opioid-related responses was observed. Naloxone-precipitated morphine withdrawal induced c-Fos expression predominantly in D2R MSNs, whereas acute morphine induced c-Fos expression exclusively in D1R MSNs.
Materials and Methods
Animals
A total of 28 male adult reporter mice (Swiss-Webster) carrying drd2-eGFP or drd1a-eGFP bacterial artificial chromosome (BAC) transgenes were used in this study (Gene Expression Nervous System Atlas; Gong et al., 2003) . Mice were kept in flow-regulated home cages (Tecniplast Smart Flow) in stable conditions of temperature (21°C) and humidity (50%), and were maintained under a 12 h light/dark cycle with food and water ad libitum. All experiments were performed according to the ethical guidelines of the National Health and Medical Research Council of Australia and were approved by the University of Sydney Animal Care and Ethics Committee.
Drugs and drug administration protocols
Morphine dependence and naloxone-precipitated withdrawal. Physical dependence to morphine was induced over a six-day period by three injections of a sustained-release morphine (free base) emulsion (300 mg/kg, GlaxoSmithKline Australia) on alternate days (days 1, 3 and 5) as described previously (Hacker et al., 2006; Bagley et al., 2011) . Briefly, M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT 5 mice were transiently anesthetized with isoflurane prior to morphine injections. The morphine base was suspended in a vehicle comprising 50% saline, 40% light liquid paraffin and 10% mannide monooleate, warmed and injected s.c. at three different sites. This sustained release preparation, originally developed by Collier et al. (1972) has been extensively used to produce sustained morphine actions for several days and opioid tolerance, and dependence without the need to subject animals to invasive surgery (e.g. Hacker et al., 2006; Chieng et al., 2005; Bagley et al., 2011) . On day 6, opioid withdrawal was precipitated by injecting naloxone (5 mg/kg i.p.) or its vehicle (isotonic saline).
Withdrawn mice were then kept in separate cages and perfused two hours after the injection. To avoid the possibility of novelty or stress-induced induction of c-Fos in NAc, opioid withdrawal signs were not explicitly scored in separate observation chambers in the present study (Hebb et al., 2004) . Nonetheless, withdrawal signs appeared comparable to those we have reported recently with the same treatment schedule (Hacker et al., 2006; Chieng et al., 2005; Bagley et al., 2011) . These included jumps, wet dog shakes, paw tremor, teeth chattering, ptosis, weight loss and diarrhea (e.g. Suppl. Table 1 in Bagley et al., 2011) . Control mice were subjected to the morphine dependence protocol but were perfused on day 6 without induction of naloxone-precipitated withdrawal, either without injection or following injection of vehicle (see Fig. 2A ).
Acute morphine protocol. A supramaximal locomotor stimulatory (e.g. Bohn et al., 2003) but non-toxic (e.g. Sora et al., 2001 ) dose of morphine-HCl (Acute morphine; 50 mg/kg, GlaxoSmithKline Australia) or vehicle (Control; 0.9% (w/v) NaCl) was injected s.c. 2 h prior to processing for immunofluorescence.
Tissue processing
Mice were rapidly anaesthetized with lethabarb (300 mg/kg, i.p., Virbac) and transcardially perfused with 4% (w/v) paraformaldehyde in 0.1 M sodium phosphate buffer (pH 7.5).
Brains were post-fixed overnight in the same solution and stored at 4°C. Unfrozen 30-µm thick sections were cut with a vibratome (VT1000, Leica Microsystems) and stored at -30°C in a solution containing 30% (vol/vol) ethylene glycol, 30% (vol/vol) glycerol and 0.1 M sodium phosphate buffer, until they were processed for immunofluorescence. Brain regions were identified using a mouse brain atlas (Dong, 2008) , and sections close to three rostrocaudal coordinates (1.42, 1.145 and 0.945 mm from Bregma) were selected for immunofluorescence. 
Immunofluorescence
Fluorescence imaging and quantification
Double-labeled images were obtained with a sequential laser scanning confocal microscope (Olympus Fluoview FV300, BX61WI microscope) using a 60X objective (UPFL 
Statistical analyses
Data are expressed as mean values ± SEM (n = 3-4 animals per group), and were analyzed using two-way ANOVA. Post hoc comparisons between groups were made using Bonferroni multiple comparison test. In all cases, significance threshold was set at p < 0.05.
Statistical analysis was performed with PRISM 5.0 software (GraphPad, Inc).
Results
drd2-eGFP BAC transgenic mice provide clear identification of the two MSN populations in the NAc core and shell
BAC transgenic mice have been established as a very good tool for the identification of the two main MSN populations in the striatum Bertran-Gonzalez et al., 2010) . drd2-eGFP mice are particularly useful because accurate distinction of D2R neurons is possible without any method of signal amplification, due to their high intensity of fluorescence (Matamales et al., 2009) . Confocal microscopy on drd2-eGFP mice combined with DARPP-32 immunostaining, a reliable marker of both populations of MSNs (Ouimet et al., 1984; Matamales et al., 2009) , was used to systematically identify D2R neurons in regions unambiguously comprised within the NAc core and the NAc shell at three different rostro-caudal levels (Fig. 1A) . Fluorescence in these mice was confined to the striatum and olfactory tubercle (Fig. 1B) , and very clearly identified D2R neurons in the selected NAc core and NAc shell regions at a higher magnification (Fig. 1B , insets 1 and 2). Double staining with DARPP-32, revealed that approximately half of the neurons expressed eGFP in both selected regions ( Fig. 1C and D) , confirming the accuracy of drd2-eGFP mice for the identification of not only D2R neurons (those expressing fluorescence) but also D1R neurons (those lacking fluorescence) (Matamales et al., 2009) .
Naloxone-precipitated opioid withdrawal induces c-Fos expression very selectively in D2R MSNs of drd2-eGFP mice
Induction of c-Fos expression has long been related to neuronal activation (Sheng and Greenberg, 1990; Hughes and Dragunow, 1995) , and has been shown to occur in striatal M A N U S C R I P T
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8 neurons in response to multiple pharmacological treatments, especially those engaging D1Rs and D2Rs (Robertson et al., 1991; Young et al., 1991; Berretta et al., 1992; Moratalla et al., 1996) . In the NAc, acute morphine injections induce strong c-Fos expression in striatal neurons (Chang et al., 1988; Garcia et al., 1995; Taracha et al., 2006) , and this activation is dependent upon D1, NMDA and µ-opioid (MOR) receptors (Liu et al., 1994; Bontempi and Sharp, 1997) . Naloxone-precipitated morphine withdrawal induces high levels of c-Fos expression in striatal neurons, an effect that is particularly strong in the NAc but less prominent in the dorsal striatum (Hayward et al., 1990; Rasmussen et al., 1995; Georges et al., 2000; Gracy et al., 2001 ).
The treatment schedule used here has consistently been reported to induce intense naloxone-precipitated withdrawal behavior (see Methods, e.g. Bagley et al., 2011) . The effect of naloxone-precipitated withdrawal on c-Fos expression was first examined in the NAc of drd2-eGFP mice (Fig. 2) . c-Fos expression was greatly enhanced in NAc core and shell 2 hours after injection of naloxone compared to controls, and almost all immunoreactivity was confined to D2R + neurons (Fig. 2B-D) . No differences in basal c-Fos expression were observed between uninjected and vehicle challenged mice (Fig. 2C, D) . In a separate experiment (Bagley et al., 2011) , we also observed low levels of basal c-Fos expression in NAc and no significant differences between three control groups (all n = 6), including chronic vehicle/saline challenge (18 ± 3 c-Fos positive neurons per series in NAc shell), chronic vehicle/naloxone challenge (20 ± 3) and chronic morphine/saline challenge (13 ±2).
During withdrawal, c-Fos immunoreactivity was profoundly elevated (319 ± 32.1 neurons, n = 4 vs. 51.5 ± 20.7, n = 4, p < 0.001) throughout the rostro-caudal extent of the NAc (see Fig. 1A for rostro-caudal levels sampled). A large, significant increase of c-Fos expression occurred in D2R + (~9-fold) versus D2R -neurons in both the NAc core and shell, whereas a smaller increase (~3 fold) was observed in D2R -neurons ( Fig. 2C and D) , which was significant (P < 0.05) only in the NAc core. The increase of c-Fos expression in D2R + neurons was significantly greater than D2R -neurons in both NAc core and shell ( Fig. 2C and D).
Naloxone-precipitated opioid withdrawal induces c-Fos expression selectively in (presumed) D2R MSNs of drd1a-eGFP mice
Recent studies have reported several behavioral and physiological alterations in drd2-eGFP mice (Kramer et al., 2011 ) that could potentially influence opioid withdrawal effects on NAc neurons. It was also not possible to rule out whether or not the trend for withdrawal-induced M A N U S C R I P T
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c-Fos in D2R -neurons could include the small populations of NAc non-MSNs in drd2-eGFP mice (Kawaguchi, 1997) . The next experiment therefore sought to confirm the distribution of naloxone-induced c-Fos expression found in D2R MSNs by using drd1a-eGFP BAC transgenic mice (Fig. 3) , another reporter line that specifically tags D1R expressing population of striatal MSNs with no major physiological alterations. After application of the same naloxone-precipitated withdrawal procedure to drd1a-eGFP mice (see Fig. 2A ), the pattern of c-Fos immunoreactivity distribution in the NAc largely matched that found in drd2-eGFP mice. As found in the drd2-eGFP mice, withdrawal-induced increased c-Fos was largely confined to presumed D2R expressing (D1R -) neurons in drd1a-eGFP mice (Fig.   3A) . As in the case of drd2-eGFP mice, rostro-caudal quantification of c-Fos-positive neurons in the NAc core of drd1a-eGFP mice also showed a large increase of c-Fos neurons (266.8 ± 12, n = 4 vs. 20.8 ± 1.6, n = 3, p < 0.0001), suggesting that overall c-Fos induction in drd2-eGFP mice was not aberrant. Overall induction of c-Fos was also similar to that we have previously reported in other mice using the same treatment protocol (Bagley et al., 2011) .
As found in the drd2-eGFP mice (see above), a large increase of immunoreactivity (~22 fold) was found in presumed D2R + (observed as D1R -) neurons of the NAc core, and a much lower and non-significant increase (∼3 fold) in D1R + neurons after naloxoneprecipitated withdrawal (Fig. 3B ). In the NAc shell, naloxone-precipitated withdrawal induced a marked increase of c-Fos immunoreactivity in D1R -neurons (~27 fold), although a smaller (~7 fold), significant increase of c-Fos immunoreactivity also occurred in D1R + neurons (Fig. 3C) . Taking the findings for drd2-eGFP and drd1a-eGFP mice together, these results clearly demonstrate that the strong neuronal activation occurring in the NAc following naloxone-precipitated withdrawal predominantly involves D2R striatopallidal MSNs of the indirect pathway, with a lesser involvement of D1R MSNs.
Acute morphine treatment induces a selective increase of c-Fos expression in D1R population of striatal MSNs
The sub-populations of NAc MSNs in which c-Fos is induced in response to acute morphine have not been studied directly. The distribution of c-Fos induction in response to a single M A N U S C R I P T
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injection of morphine (50 mg/kg) was examined in drd2-eGFP mice (Fig. 4) . Two hours after injection, morphine-treated mice displayed an increase in c-Fos immunoreactive neurons in both the core and shell of the NAc compared to vehicle controls (Fig. 4A) , confirming the effects of this drug in ventral striatal regions (Garcia et al., 1995; Bontempi and Sharp, 1997; Taracha et al., 2006) . Although significant, the overall induction of c-Fos by acute morphine was substantially less than that observed during naloxone-precipitated withdrawal (77.9 ± 9.08, n = 4 vs. 35.33 ± 2.4, n = 3, p < 0.05), particularly in the NAc core (Fig. 4B, C) .
Interestingly, co-localization with eGFP revealed that the morphine-induced increase in cFos immunoreactive neurons occurred exclusively in neurons that did not express eGFP fluorescence (Fig, 4A) . The quantification study revealed that, whereas both eGFP-positive (D2R + ) and eGFP-negative (D2R -) neurons expressed equivalent basal levels of c-Fos immunoreactive neurons, acute morphine treatment increased c-Fos expression selectively in D2R -neurons, whereas D2R + c-Fos levels remained unchanged (Fig. 4B, C) . As previously reported (Taracha et al., 2006) , the extent of neuronal activation was found to be higher in the NAc shell, although the distribution of the activated cells was restricted to D2R -neurons in both NAc core and shell (Fig. 4B, C) . These results suggest the exclusive activation of the D1R striatonigral system of the NAc in response to a single injection of morphine.
Discussion
The aim of the present study was to unambiguously identify the sub-populations of MSNs activated by naloxone-precipitated opioid-withdrawal, as well as acute morphine, in the NAc since both opioid-related conditions generate strong cellular responses in ventral striatal neurons despite their very different neurobehavioral effects. To this end, we took advantage of the recently generated BAC transgenic reporter mouse lines (Gong et al., 2003) , which have been shown to be useful for sensitive and selective identification of the two different (Matamales et al., 2009 ). Using these mice we found a striking segregation between the MSNs engaged by withdrawal (predominantly D2R MSNs) and acute morphine (exclusively D1R MSNs), respectively.
The mechanisms responsible for selective engagement of D2R neurons during opioid withdrawal are not certain. Although opioid withdrawal directly modulates synaptic activity in NAc neurons in vitro (e.g. Chieng and Williams, 1998) , most studies suggest that the effects of morphine withdrawal in the NAc are a consequence of alterations of dopamine neuron firing in the VTA (Williams et al., 2001 ) and are not due to a local regulation of MOR . In contrast to the effects of acute morphine, morphine withdrawal induces a profound depression of dopamine neuron activity in the VTA (Diana et al., 1995) , both through enhanced GABAergic (Madhavan et al., 2010) and decreased glutamatergic transmission onto these neurons (Manzoni and Williams, 1999) . Opioid withdrawal also enhances c-Fos expression in GABAergic VTA neurons (Bagley et al., 2011 ). An intriguing question from these studies is how an abrupt and virtually complete cessation of dopamine neuron firing induced by morphine withdrawal (Diana et al., 1995) can lead to such a strong neuronal activation in ventral striatal regions (Hayward et al., 1990; Rasmussen et al., 1995; Georges et al., 2000; Gracy et al., 2001) . It is tempting to speculate that nearly complete elimination of dopamine release in the NAc during withdrawal removes the sustained stimulation of high affinity, inhibitory D2Rs (Richfield et al., 1989) . This would be expected to trigger the strongly segregated neuronal responses in neurons containing D2Rs observed in the present study because the sustained, Gα i -mediated inhibition of cAMP signaling by D2Rs would be released, as has been shown to occur in response to D2R blockade in the dorsal striatum .
If the mechanism of selective c-Fos induction in D2R versus D1R MSNs did depend indirectly on dopamine tone, this might also explain the selective induction of c-Fos in D1R + after acute administration of morphine. It is generally accepted that acute effects of systemic morphine on striatal neurons are the consequence of a strong regulation exerted by GABAergic interneurons of the VTA on dopamine neurons through a MOR-dependent mechanism (Di Chiara and North, 1992; Johnson and North, 1992) . Accordingly, systemically administered morphine stimulates MORs strongly expressed in midbrain GABAergic synapses, which engages Gα i -mediated intracellular signaling events that decrease the GABAergic tone exerted on dopamine neurons of the VTA (Di Chiara and M A N U S C R I P T Johnson and North, 1992) , presumably arising from local GABAergic interneurons (Johnson and North, 1992; Chieng et al., 2011) and GABAergic rostromedial tegmental nucleus neurons (Jalabert et al., 2011; Matsui and Williams, 2011 ). This in turn disinhibits dopamine neurons, inducing release of dopamine in target regions such as the NAc. Importantly, enhanced dopamine release in the NAc caused by other stimuli produces strong c-Fos induction in MSNs, an effect that has been shown to be dependent upon D1-and NMDA-receptors (Liu et al., 1994; Bontempi and Sharp, 1997) . Since c-Fos expression (as well as a multitude of other signaling events; Valjent et al., 2009 ) is mediated by D1Rs in response to drugs increasing dopamine tone, only neurons expressing these receptors are expected to be excited after acute morphine administration, as was observed after administration of psychostimulants (Bertran-Gonzalez et al., 2008) .
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It is difficult to reconcile our findings with the double in situ hybridization study of Georges et al. (2000) in morphine-withdrawn rats. In their study, naltrexone-precipitated withdrawal induced c-fos mRNA expression with a trend for selective expression in D1R mRNApositive and pre-pro-enkephalin A mRNA-negative (striatonigral) neurons of the NAc (Georges et al., 2000) . Interestingly, however, they reported in the same animals a preferential distribution of c-fos mRNA in striatopallidal (presumably D2R positive) neurons of dorsal striatal regions. Besides possible differences due to species, the method of MSN phenotyping (in situ hybridization vs. targeted expression of eGFP) and/or neuronal activity detection (mRNA vs. protein), the different degrees of D1R and D2R co-expression reported in different striatal territories may explain the contrasting results (Bertran-Gonzalez et al., 2008; Perreault et al., 2010) . It is important to consider recent estimates of D1R and D2R co-expressing neurons performed in BAC transgenic mice, in which only 5% of the MSNs are estimated to co-express these receptors in the dorsal striatum and the NAc core, whereas up to 17% of the MSNs seem to do so in the NAc shell (Bertran-Gonzalez et al., 2008; Matamales et al., 2009 ).
Importantly, co-expression D1R and D2R in ~17% of MSNs in NAc shell could also reconcile the differences observed here in drd1a-and drd2-eGFP mice following morphine already exist, and should help to resolve this question (Shuen et al., 2008; Ade et al., 2011) .
Conclusions
In conclusion, the present study has identified clearly segregated cellular activation D2R
and D1R 
